http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070072550-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C-
filingDate 2005-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b27b67708fd86e09f488636bf53c711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7180264136e2837b75c6c7254ce276a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a21096e1f6c8eae764d6cb82501b55b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_935c70f6ca50e82f5d89cfa8d37e5aca
publicationDate 2007-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20070072550-A
titleOfInvention Novel sulfonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
abstract The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, a process for its preparation and its use in medical therapy (eg glucocorticoid receptor modulation in warm blooded animals).n n n  <Formula I>
priorityDate 2004-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58287513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID464975413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413213354

Total number of triples: 35.